Vitamin A–mediated targeting of small interfering (si)RNA to stellate cells reverses liver cirrhosis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo
Journal of Cell Communication and Signaling Open Access 18 March 2009
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sato, Y. et al. Nat. Biotechnol., 431–442 (2008).
Friedman, S.L. Physiol. Rev. 88, 125–172 (2008).
Blomhoff, R., Berg, T. & Norum, K.R. Proc. Natl. Acad. Sci. USA 85, 3455–3458 (1988).
Masuda, H., Fukumoto, M., Hirayoshi, K. & Nagata, K. J. Clin. Invest. 94, 2481–2488 (1994).
Nagata, K. Matrix Biol. 16, 379–386 (1998).
Brown, K.E., Broadhurst, K.A., Mathahs, M.M., Brunt, E.M. & Schmidt, W.N. Lab. Invest. 85, 789–797 (2005).
Murphy, F.R. et al. J. Biol. Chem. 277, 11069–11076 (2002).
Pinzani, M., Vizzutti, F., Arena, U. & Marra, F. Nat. Clin. Pract. Gastroenterol. Hepatol. 5, 95–106 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Friedman, S. Targeting siRNA to arrest fibrosis. Nat Biotechnol 26, 399–400 (2008). https://doi.org/10.1038/nbt0408-399
Issue Date:
DOI: https://doi.org/10.1038/nbt0408-399
This article is cited by
-
Evolving challenges in hepatic fibrosis
Nature Reviews Gastroenterology & Hepatology (2010)
-
Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo
Journal of Cell Communication and Signaling (2009)